KDM5A and neoplasm: Inhibition of KDM5A with small molecule inhibitors such as the pan-KDM inhibitor JIB 04 and the selective KDM5A inhibitor CP1445 efficiently inhibited tumor growth in vitro and in vivo of TMZ-resistant GBM [120,121].